Peter Rahmer Relay Therapeutics, Inc. (RLAY) insider trading activity

Peter Rahmer is of Relay Therapeutics, Inc.. Currently has a direct ownership of 391,929 shares of RLAY, which is worth approximately $2.44 Million. The most recent transaction as insider was on Jul 31, 2024, when has been sold 13,708 shares (Common Stock) at a price of $8.19 per share, resulting in proceeds of $112,268. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 392K

9.36% 3M change

23.71% 12M change

Total Value Held $2.44 Million

Peter Rahmer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 31 2024	SELL Open market or private sale	$112,268 $8.19 p/Share	13,708 Reduced 3.38%	391,929 Common Stock
Jul 30 2024	SELL Open market or private sale	$125,259 $8.28 p/Share	15,128 Reduced 3.6%	405,637 Common Stock
Jul 29 2024	SELL Open market or private sale	$117,379 $8.68 p/Share	13,523 Reduced 3.11%	420,765 Common Stock
Jun 30 2024	BUY Grant, award, or other acquisition	$11,678 $5.54 p/Share	2,108 Added 0.48%	434,288 Common Stock
Jun 27 2024	SELL Open market or private sale	$1,533 $6.26 p/Share	245 Reduced 0.06%	432,180 Common Stock
Jun 05 2024	SELL Open market or private sale	$144,377 $7.06 p/Share	20,450 Reduced 4.52%	432,425 Common Stock
Jun 04 2024	SELL Open market or private sale	$269,550 $6.64 p/Share	40,595 Reduced 8.23%	452,875 Common Stock
Jun 03 2024	SELL Open market or private sale	$128,520 $6.47 p/Share	19,864 Reduced 3.87%	493,470 Common Stock
Apr 29 2024	SELL Open market or private sale	$8,581 $6.38 p/Share	1,345 Reduced 0.26%	513,334 Common Stock
Mar 27 2024	SELL Open market or private sale	$2,294 $7.7 p/Share	298 Reduced 0.06%	514,679 Common Stock
Jan 29 2024	SELL Open market or private sale	$15,915 $9.64 p/Share	1,651 Reduced 0.32%	514,977 Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	-	200,000 Added 27.91%	516,628 Common Stock
Dec 27 2023	SELL Open market or private sale	$2,808 $11.51 p/Share	244 Reduced 0.08%	316,628 Common Stock
Oct 30 2023	SELL Open market or private sale	$8,164 $6.03 p/Share	1,354 Reduced 0.43%	316,872 Common Stock
Sep 27 2023	SELL Open market or private sale	$2,044 $8.38 p/Share	244 Reduced 0.08%	318,226 Common Stock
Jul 28 2023	SELL Open market or private sale	$15,953 $11.8 p/Share	1,352 Reduced 0.42%	316,808 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$17,750 $10.68 p/Share	1,662 Added 0.52%	319,822 Common Stock
Jun 27 2023	SELL Open market or private sale	$2,957 $12.12 p/Share	244 Reduced 0.08%	318,160 Common Stock
May 30 2023	BUY Grant, award, or other acquisition	-	161,818 Added 33.7%	318,404 Common Stock
Apr 28 2023	SELL Open market or private sale	$8,247 $11.16 p/Share	739 Reduced 0.47%	157,504 Common Stock
Mar 27 2023	SELL Open market or private sale	$4,561 $15.36 p/Share	297 Reduced 0.19%	158,243 Common Stock
Jan 30 2023	SELL Open market or private sale	$15,954 $21.56 p/Share	740 Reduced 0.46%	158,540 Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	-	97,630 Added 38.0%	159,280 Common Stock

Peter Rahmer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLAY shares.

Notify only if

Value

Insider Trading

Get notified when an Relay Therapeutics, Inc. insider buys or sells RLAY shares.

Notify only if

Operation

Value

Type

News

Receive news related to Relay Therapeutics, Inc.

Track Activities on RLAY

Account